BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 781579)

  • 21. Efficacy of immunotherapy for metastatic mucosal melanoma.
    Shreders A; Joseph RW
    Immunotherapy; 2016 Jul; 8(8):843-5. PubMed ID: 27381682
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotherapy in malignant melanomaa.
    Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
    Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant melanoma of the nasal cavity and paranasal sinuses.
    Lund V
    J Laryngol Otol; 1982 Apr; 96(4):347-55. PubMed ID: 7061932
    [No Abstract]   [Full Text] [Related]  

  • 24. [Management of melanoma in the nose and paranasal cavity].
    Saito H
    Nihon Jibiinkoka Gakkai Kaiho; 1981 Apr; 84(4):452-5. PubMed ID: 7288525
    [No Abstract]   [Full Text] [Related]  

  • 25. [Melanoma of the nasal fossae and sinuses, apropos of a series of 7 cases].
    Vinel V; Dehesdin D; Marie JP
    Rev Laryngol Otol Rhinol (Bord); 1990; 111(1):61-5. PubMed ID: 2130402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract]   [Full Text] [Related]  

  • 27. Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients.
    Grooms GA; Eilber FR; Morton DL
    J Surg Oncol; 1977; 9(2):147-53. PubMed ID: 325299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined treatment and rehabilitation of patients with malignant nasal and paranasal sinus tumors].
    Seniukov MV; Shanturov AG
    Vestn Otorinolaringol; 1982; (1):52-7. PubMed ID: 7064283
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical analysis of 23 primary sinonasal malignant melanoma].
    Wang Y; Guan B; Xu L; Xu Y; Zhang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Oct; 28(20):1559-61. PubMed ID: 25764752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCG immunotherapy in patients with malignant melanoma.
    Karakousis CP; Douglass HO; Yeracaris PM; Holyoke ED
    Arch Surg; 1976 Jun; 111(6):716-8. PubMed ID: 776125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of immunologic status of patients receiving BCG therapy for malignant disease.
    Gross NJ; Eddie-Quartey AC
    Cancer; 1976 May; 37(5):2183-93. PubMed ID: 769946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intralesional BCG in the treatment of metastatic malignant melanoma.
    Mastrangelo MJ; Sulit HL; Prehn LM; Bornstein RS; Yarbro JW; Prehn RT
    Cancer; 1976 Feb; 37(2):684-92. PubMed ID: 766947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic quiz case 1. Malignant melanoma.
    Carter TR
    Arch Otolaryngol Head Neck Surg; 1986 Apr; 112(4):450-3. PubMed ID: 3947466
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunology and cutaneous malignant melanoma.
    Sober AJ
    Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral bacille Calmette Guérin immunostimulation in malignant melanoma.
    MacGregor AB; Falk RE; Landi S; Ambus U; Langer B
    Surg Gynecol Obstet; 1975 Nov; 141(5):747-54. PubMed ID: 1105837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autologous tumor-specific immunotherapy for recurrent malignant melanoma of the nasal cavity].
    Nishiura Y; Sakamoto K; Mihoki T; Takane Y; Maeda A; Miyajima Y; Nakashima T
    Nihon Jibiinkoka Gakkai Kaiho; 2006 Nov; 109(11):781-4. PubMed ID: 17165592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant amelanotic melanomas of the nasal septum and maxillary sinus.
    Crone RP
    Laryngoscope; 1966 Nov; 76(11):1826-33. PubMed ID: 5924329
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant melanoma and immunotherapy.
    Br Med J; 1976 Oct; 2(6040):831-2. PubMed ID: 791438
    [No Abstract]   [Full Text] [Related]  

  • 39. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
    Wile AG; Sparks FC; Morton DL
    Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the results of combined treatment of malignant neoplasms of the nose and accessory sinuses].
    Shtil' AA
    Vestn Otorinolaringol; 1974; 2():49-53. PubMed ID: 4832911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.